about
Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and LipidomicsHDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applicationsProtein carbamylation and cardiovascular diseaseThe emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolismModified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic ToxinsResidual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density LipoproteinHDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approachA pro-atherogenic HDL profile in coronary heart disease patients: an iTRAQ labelling-based proteomic approachAssociations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysisHigh-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitorsAnti-psoriatic therapy recovers high-density lipoprotein composition and function.HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotypeDecrease in irisin in patients with chronic kidney diseaseDysfunctional high-density lipoproteins in children with chronic kidney diseaseAging affects high-density lipoprotein composition and function.Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.Biochemical and functional characterization of charge-defined subfractions of high-density lipoprotein from normal adults.Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.Restoration of renal function does not correct impairment of uremic HDL propertiesThe role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney diseaseIncreased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate.Dialysis Modalities and HDL Composition and FunctionAssociation of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho.A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects.Cholesterol Metabolism in CKDCardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities.A Comparison of Methods To Enhance Protein Detection of Lipoproteins by Mass SpectrometryPsoriasis alters HDL composition and cholesterol efflux capacityD25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile.Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein functionApoprotein B/Apoprotein A-1 Ratio and Mortality among Prevalent Dialysis Patients.Role of HDL dysfunction in end-stage renal disease: a double-edged sword.Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients.Antibodies against carbamylated proteins are present in primary Sjögren's syndrome and are associated with disease severity.Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyondUnraveling the complexities of the HDL lipidomeMolecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.Refined purification strategy for reliable proteomic profiling of HDL2/3: Impact on proteomic complexity.
P2860
Q26774903-A7DC8A00-F937-45A5-812D-399EAD5131E2Q26779667-B93ED7ED-C95C-442D-87E9-01E62230CD61Q26827410-F21DDDD7-AA92-48C0-AC70-F5B0CBFDEBACQ28072835-760D26D0-44CA-45F9-9B61-D2A4CAE043D5Q28074264-EBBE9732-3C4C-4882-9D87-0347FEB1C6C3Q28083619-12B391ED-9711-416B-9E62-78684DA874D4Q28481613-7617AD99-2466-4420-8D24-2041C56DD3C8Q33655192-518BB324-3158-4462-9261-8DA53AB03881Q33704372-D4155FED-AE3E-4451-B518-FA4B2F387AF6Q34157008-9BA2996E-C69C-4B61-914C-96E5E931563FQ34178582-E1403E85-9D22-40A6-BAC1-6FF7446C130EQ34259215-3AD4CFFB-5E50-4D9D-97FF-925169A70592Q34427695-1AA80158-6208-43BE-9650-DFB34D00741FQ34718513-A13EA9DF-3843-496B-9266-45EBE4609015Q34779002-F5D94ED1-0F7B-43A8-8D90-B95C1A2160CAQ34781392-27AF5981-D152-4259-A299-659A91B40A93Q34835301-8DD25528-16CF-4E5E-918A-AE6C4C198ECDQ35027220-9FFB71F6-9812-4B25-93E4-6C49855D064DQ35028691-650A4EFB-DC70-47B1-9493-DDF9BE3841F5Q35051225-1ED37540-F7CE-4300-BFD6-1FE93C35FC5AQ35124223-6AF6248C-C6DC-4695-B3F1-FEA12D3BED37Q35530832-1EBF795C-6F85-4999-8D55-99316AE22CB3Q35996626-F994508F-59E4-4609-B925-3BD49B75EF23Q36003077-F27871AF-AAE2-43F0-BF2C-10C0E90692D1Q36197717-8B8E60A6-379F-4B90-96A4-9E4416DA6641Q36257138-A9554A54-B26B-4395-9AC1-49205432DDAFQ36315574-AA63CE40-A417-444B-983F-B6C6371B72B2Q36419283-E1D1B26C-9CF6-4978-8C1E-5AFC4FB5FF12Q36467197-A33EB0FC-6C0D-4F3C-AE1D-05B32129841DQ36520321-7786F19C-5CD6-4D65-98D9-9DB3D205078DQ36528525-3310831D-838A-4C4E-970F-23B68F94077AQ36681220-DF3A86D5-DB39-406E-9DAB-336266F6BE92Q36874560-0D3FBF4F-B7FF-4341-8812-9284A333C0DAQ36876162-5ABE0C53-FCBA-401B-A983-C29FD7C50AC6Q37100557-5E665D4C-DB5D-4566-879F-3508C3217347Q37156391-B6538074-A970-4022-A752-85B3B9D95904Q37162996-7389CBC2-71F5-4599-9148-4DC21EB04827Q37222656-483FC227-933C-4347-92D8-25EB64A764D3Q37254899-4265BA8B-7B0B-4903-980B-9CB0472C109BQ37472192-729B8475-C6AA-4BD0-B3A3-E6B535C28183
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Uremia alters HDL composition and function
@ast
Uremia alters HDL composition and function
@en
type
label
Uremia alters HDL composition and function
@ast
Uremia alters HDL composition and function
@en
prefLabel
Uremia alters HDL composition and function
@ast
Uremia alters HDL composition and function
@en
P2093
P2860
P50
P356
P1476
Uremia alters HDL composition and function
@en
P2093
Christian Wadsack
Dalia El-Gamal
Tatjana Stojakovic
Veronika Binder
P2860
P304
P356
10.1681/ASN.2010111144
P577
2011-07-29T00:00:00Z